660 research outputs found
Viscoelastic behaviour and fracture toughness of linear-low-density polyethylene reinforced with synthetic boehmite alumina nanoparticles
Systematic review and meta-analysis of surgical drain management after the diagnosis of postoperative pancreatic fistula after pancreaticoduodenectomy: draining-tract-targeted works better than standard management
Drains' role after pancreaticoduodenectomy (PD) is debated by proponents of no drain, draining selected cases, and early drain removal. The aim of the study was to assess the effect of "standard" and "draining-tract-targeted" management of abdominal drains still in situ after diagnosing a postoperative pancreatic fistula (POPF)
Beyond measurement: taking bold multisector actions towards zero catastrophic costs and suffering due to TB.
Using the Process Digital Twin as a tool for companies to evaluate the Return on Investment of manufacturing automation
The fourth industrial revolution is gaining momentum, but still lacks full realization. Several studies suggest that many companies around the world have begun the digital transformation undertaking, but most are still far from full adoption and yet fail to see the full economic potential, being stuck in what has been called "pilot purgatory”. Digitalization is largely recognized as an accelerator and enabler for full automation in manufacturing, but companies are still struggling to assess the return on investment and the impact on operational performance indicators. Therefore, companies, especially SMEs characterized by dynamic, high-value, high-mix, and low-volume contexts, are reluctant to invest further. By incorporating simulation, data analytics and behavioral models, digital twins may also be used to support automation solutions ramp-up, demonstrate their impact evaluation, usage scenarios, eliminating the need for physical prototypes, reducing development time, and improving quality. Few forward-thinking companies are pursuing the digital transformation path, while the majority are clipping the wings of a transformation that is essential for a sustainable manufacturing. This paper describes a theoretical approach to exploit the digital twin technology to gather insights towards a realistic economical assessment of full automation solutions, to back and encourage investments to realize the potential of the digital manufacturing transformation. The approach is being tested under the European Union’s Horizon 2020 research and innovation program under grant agreement No. 958363, which provides an opportunity to assess how the various components of the method are constructed, how complex they are, and what level of effort is required, using a practical example
Duodenal Leiomyosarcoma Mimicking a Pancreatic Pseudocyst
A case of duodenal leiomyosarcoma presenting as a cystic mass is reported. Amylase, tumour
markers levels in the cyst fluid and radiological findings suggested an inflammatory pancreatic
pseudocyst. Exploratory laparotomy and frozen section examination showed a smooth muscle
tumour of the duodenum. Pancreatoduodenectomy with pylorus-preser vation was performed
and the patient remained symptom-free at 8 months follow-up
Comportamento de cĂłpula de Spodoptera eridania (Walker) (Lepidoptera: Noctuidae).
Pouco se conhece sobre o comportamento de cĂłpula de Spodoptera eridania (Walker) (Lepidoptera: Noctuidae), praga que tem ganhado importância nos Ăşltimos anos em vários cultivos agrĂcolas. Para tanto, foram estudados 61 casais virgens, durante oito noites apĂłs a emergĂŞncia, em intervalos de 15 min, durante 14 horas. Os casais foram transferidos para tubo de PVC transparente e alimentados com solução de mel a 10%. Foi determinado a idade da primeira cĂłpula, o nĂşmero de cĂłpulas por casal, o nĂşmero de espermatĂłforos transferidos para cada fĂŞmea e o horário de cĂłpula. Os adultos copularam desde a primeira atĂ© a sĂ©tima noite apĂłs a emergĂŞncia. Na primeira noite mais de 76% dos casais realizaram a primeira cĂłpula, e atĂ© a quarta noite mais de 95% do total de cĂłpulas foi observado. A partir da quarta noite, alĂ©m da redução no nĂşmero de cĂłpulas, 50% das mesmas que ocorreram neste perĂodo tiveram duração inferior a 15 min, nĂŁo caracterizando uma cĂłpula duradoura onde pudesse haver a transferĂŞncia de espermatĂłforos. Quando foram correlacionados o nĂşmero de cĂłpulas por casal com o nĂşmero de espermatĂłforos transferido para a fĂŞmea (correlação de 0,77), notou-se que nos casais onde houve estas cĂłpulas rápidas, o nĂşmero de espermatĂłros foi menor que o nĂşmero de cĂłpulas, sugerindo que nĂŁo houve a transferĂŞncia de espermatĂłforos, caracterizando este comportamento como tentativa de cĂłpula e nĂŁo como cĂłpula efetiva. Outro aspecto observado no comportamento de S. eridania foi que 56% dos casais realizaram apenas uma cĂłpula ao longo dos oito dias de avaliação, evidenciando uma tendĂŞncia a "monoandria". O horário das cĂłpulas foi predominantemente na oitava e nona hora da escotofase, se estendendo atĂ© a 11ÂŞ hora
Simple Detection of Large InDeLS by DHPLC: The ACE Gene as a Model
Insertion-deletion polymorphism (InDeL) is the second most frequent type of genetic variation in the human genome. For the detection of large InDeLs, researchers usually resort to either PCR gel analysis or RFLP, but these are time consuming and dependent on human interpretation. Therefore, a more efficient method for genotyping this kind of genetic variation is needed. In this report, we describe a method that can detect large InDeLs by DHPLC (denaturating high-performance liquid chromatography) using the angiotensin-converting enzyme (ACE) gene I/D polymorphism as a model. The InDeL targeted in this study is characterized by a 288 bp Alu element insertion (I). We used DHPLC at nondenaturating conditions to analyze the PCR product with a flow through the chromatographic column under two different gradients based on the differences between D and I sequences. The analysis described is quick and easy, making this technique a suitable and efficient means for DHPLC users to screen InDeLs in genetic epidemiological studies
Genome-scaled phylogeny of Saccharomyces cerevisiae from spontaneous must fermentations
Modern winemakers commonly inoculate selected S. cerevisiae strains in must to obtain controlled fermentations and reproducible products. However, wine has been produced for thousands of years using spontaneous fermentations from wild strains, a practice that is experiencing a revival among small wine producers. Despite the widespread usage of such strains in the past, there is much to know about their ecology, evolution and functional potential. For example, the reciprocal affinities of these strains within the S. cerevisiae phylogeny have yet to be discovered, as well as the degree of their biodiversity and their impact on wine terroir. To fill this knowledge gap, we aim at characterising at strain level the S. cerevisiae present in spontaneously fermented musts sampled across Italy. We set up a protocol based on polyphenols-removing prewashes, followed by whole-genome shotgun sequencing at a depth of 5Gb of DNA per sample. We performed both an assembly-free analysis to reconstruct the strain-level phylogeny of S. cerevisiae strains using the species-specific-marker based StrainPhlAn, and the reconstruction of Metagenome-Assembled Genomes of these strains for downstream functional analyses. To plan conservation acts in a scenario of continuous climate change, we aim at isolating and maintaining strains of interest. We will present preliminary results from the analysis of spontaneous musts sampled at different fermenting stages
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma
Cancer therapy; Phase I trialsTerà pia del cà ncer; Assajos de fase ITerapia del cáncer; Ensayos de fase IBackground
The first-in-class brain-penetrating synthetic hydroxylated lipid idroxioleic acid (2-OHOA; sodium 2-hydroxyoleate), activates sphingomyelin synthase expression and regulates membrane-lipid composition and mitochondrial energy production, inducing cancer cell autophagy. We report the findings of a multicentric first-in-human Phase 1/2A trial (NCT01792310) of 2-OHOA, identifying the maximum tolerated dose (MTD) and assessing safety and preliminary efficacy.
Methods
We performed an open-label, non-randomised trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumour activity of daily oral treatment with 2-OHOA monotherapy (BID/TID) in 54 patients with glioma and other advanced solid tumours. A dose-escalation phase using a standard 3 + 3 design was performed to determine safety and tolerability. This was followed by two expansion cohorts at the MTD to determine the recommended Phase-2 dose (RP2D).
Results
In total, 32 recurrent patients were enrolled in the dose-escalation phase (500–16,000 mg/daily). 2-OHOA was rapidly absorbed with dose-proportional exposure. Treatment was well-tolerated overall, with reversible grade 1–2 nausea, vomiting, and diarrhoea as the most common treatment-related adverse events (AEs). Four patients had gastrointestinal dose-limiting toxicities (DLTs) of nausea, vomiting, diarrhoea (three patients at 16,000 mg and one patient at 12,000 mg), establishing an RP2D at 12,000 mg/daily. Potential activity was seen in patients with recurrent high-grade gliomas (HGG). Of the 21 patients with HGG treated across the dose escalation and expansion, 5 (24%) had the clinical benefit (RANO CR, PR and SD >6 cycles) with one exceptional response lasting >2.5 years.
Conclusions
2-OHOA demonstrated a good safety profile and encouraging activity in this difficult-to-treat malignant brain-tumour patient population, placing it as an ideal potential candidate for the treatment of glioma and other solid tumour malignancies.
Clinical trial registration
EudraCT registration number: 2012-001527-13; Clinicaltrials.gov registration number: NCT01792310.This study was supported in part by Laminar Pharmaceuticals. Financial support was also provided by the Govern de les Illes Balears i del Fons Social Europeu (ES01/TCAI/53_2016, ES01/TCAI/21_2017, ES01/TCAI/24_2018 and PROCOE/5/2017), the European Commission (H2020 Framework Programmes Project CLINGLIO 755179), Cancer Research UK (C9380/A25138) and the Experimental Cancer Medicine Centre Network (C9380/A25169). VL was supported by a Torres-Quevedo Research contract from the Spanish Ministerio de EconomĂa y Competitividad (PTQ-17-09056), co-funded by the FSE
- …